# Cognition, Functioning and Quality of Life

> **NCT00182442** · PHASE4 · COMPLETED · sponsor: **Hamilton Health Sciences Corporation** · enrollment: 80 (—)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Olanzapine & Quetiapine

## Key facts

- **NCT ID:** NCT00182442
- **Lead sponsor:** Hamilton Health Sciences Corporation
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** —
- **Final completion:** 2006-03
- **Target enrollment:** 80 (—)
- **Last updated:** 2006-10-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00182442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00182442, "Cognition, Functioning and Quality of Life". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00182442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*